Tech Company Inital Public Offerings
Enanta Pharmaceuticals IPO
On 3/21/2013, Enanta Pharmaceuticals went public.
Transaction Overview
Company Name
Announced On
3/21/2013
Transaction Type
IPO
Amount
$56,000,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
500 Arsenal St.
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Overview
Enanta is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Luly
Chief Financial Officer
Paul Mellett
Chief Medical Officer
Nathalie Adda
Chief Scientific Officer
Yat Or
VP - General Counsel
Nathaniel Gardiner
Browse more venture capital transactions:
Prev: 3/21/2013: Dachis Group venture capital transaction
Next: 3/22/2013: Decide.com venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs